Rojas Juan I, Pappolla Agustín, Blaya Patricio, Marrodán Mariano, Ysrraelit María C, Luetic Geraldine, Liwacki Susana, Barboza Andrés, Burgos Marcos, Cohen Leila, Mainella Carolina, Zanga Gisela, Menichini María L, Tavolini Dario, Tkachuk Verónica, Lopez Pablo, Lequizamon Felisa, Knorre Eduardo, Nofal Pedro, Patrucco Liliana, Miguez Jimena, Cristiano Edgardo, Fiol Marcela, Correale Jorge, Gaitán María I, Alonso Ricardo, Silva Berenice, Garcea Orlando, Carrá Adriana, Fernandez Liguori Nora, Alonso Serena Marina, Carnero Contentti Edgar
Centro de Esclerosis Múltiple de Buenos Aires, (CEMBA), Billinghurst 1611, CP 1181, Buenos Aires, Argentina.
Servicio de Neurología, Unidad de EM y Enfermedades Desmielinizantes, Hospital Universitario de CEMIC, Buenos Aires, Argentina.
J Neurol. 2022 Apr;269(4):2073-2079. doi: 10.1007/s00415-021-10791-4. Epub 2021 Sep 7.
We aimed to analyze the accumulative risk of MRI and OB factors for evolution from RIS to MS in subjects included in the Argentinean MS registry (NCT03375177).
RIS subjects were identified according to RIS diagnosis criteria. Subjects were longitudinally followed with clinical and MRI at intervals of 6 months. Time from RIS identification to the first clinical event was estimated using Kaplan-Meier. Multivariable Cox regression models were created to assess the independent predictive value of demographic characteristics, as well as clinical, OB and MRI data on time to the first clinical event. The single and increased risk factor of evolution of RIS was quantified.
A total of 88 RIS subjects, mean follow-up time 42 ± 4 months were included. 39 (44.3%) and 23 (26.1%) had a new MRI lesion or a clinical event, respectively, during the follow-up. OB (HR 5.9, 95% CI 1.29-10.1, p = 0.004), infratentorial lesions (HR 3.7, 95% CI 1.09-7.5) and spinal cord lesions (HR 5.3, 95% CI 1.4-8.2, p = 0.01) at RIS identification were independent predictors associated with a subsequent clinical event. The accumulative risk showed that when two of the three factors (OB, infratentorial or spinal cord lesions) were present the HR was 10.4, 95% CI 4.4-22, p < 0.001, and when three factors were present, it was HR 15.6, 95% CI 5.7-28, p < 0.001 for a relapse.
The presence of three factors significantly increased the risk of clinical event; high-risk subjects should probably be managed by a different approach than those used for individuals without high-risk factors.
我们旨在分析阿根廷多发性硬化症登记处(NCT03375177)纳入的受试者中,MRI和客观存在的(OB)因素对于从风险不确定综合征(RIS)进展为多发性硬化症(MS)的累积风险。
根据RIS诊断标准确定RIS受试者。受试者每6个月接受一次临床和MRI纵向随访。使用Kaplan-Meier法估计从确定RIS到首次临床事件的时间。创建多变量Cox回归模型,以评估人口统计学特征以及临床、OB和MRI数据对首次临床事件发生时间的独立预测价值。对RIS进展的单一和增加的风险因素进行量化。
共纳入88名RIS受试者,平均随访时间为42±4个月。随访期间,分别有39名(44.3%)和23名(26.1%)出现了新的MRI病变或临床事件。确定RIS时存在OB(风险比[HR]5.9,95%置信区间[CI]1.29 - 10.1,p = 0.004)、幕下病变(HR 3.7,95% CI 1.09 - 7.5)和脊髓病变(HR 5.3,95% CI 1.4 - 8.2,p = 0.01)是与随后临床事件相关的独立预测因素。累积风险显示,当三个因素中的两个(OB、幕下或脊髓病变)存在时,复发的HR为10.4,95% CI 4.4 - 22,p < 0.001;当三个因素都存在时,HR为15.6,95% CI 5.7 - 28,p < 0.001。
三个因素的存在显著增加了临床事件的风险;高危受试者可能需要采用与无高危因素个体不同的管理方法。